OXTOX: Can Oxaliplatin neurotoxicity be reduced with ibudilast in people with metastatic colorectal cancer a phase II randomised study
Latest Information Update: 18 Apr 2022
At a glance
- Drugs Ibudilast (Primary)
- Indications Chemotherapy-induced damage
- Focus Adverse reactions
- Acronyms OXTOX
Most Recent Events
- 16 Apr 2021 Planned End Date changed from 31 Dec 2020 to 30 Jun 2022.
- 16 Apr 2021 Status changed from not yet recruiting to recruiting.
- 11 Apr 2019 Anticipated date for last participant enrollment is 30 June 2020.